These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1315900)

  • 21. Vasopressin-stimulated phosphoinositide hydrolysis in cultured rat inner medullary collecting duct cells is mediated by the oxytocin receptor.
    Teitelbaum I
    J Clin Invest; 1991 Jun; 87(6):2122-6. PubMed ID: 1645753
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [125I]-[d(CH2)5, Sar7]AVP: a selective radioligand for V1 vasopressin receptors.
    Kelly JM; Abrahams JM; Phillips PA; Mendelsohn FA; Grzonka Z; Johnston CI
    J Recept Res; 1989; 9(1):27-41. PubMed ID: 2521670
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hormonally active arginine-vasopressin suppresses endotoxin-induced fever in rats: lack of effect of oxytocin and a behaviorally active vasopressin fragment.
    Kovács GL; De Wied D
    Neuroendocrinology; 1983 Oct; 37(4):258-61. PubMed ID: 6355890
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Direct cardiac effects of vasopressin: role of V1- and V2-vasopressinergic receptors.
    Walker BR; Childs ME; Adams EM
    Am J Physiol; 1988 Aug; 255(2 Pt 2):H261-5. PubMed ID: 2970231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction between V1 and V2 effects in hemodynamic response to vasopressin in dogs.
    Liard JF
    Am J Physiol; 1990 Feb; 258(2 Pt 2):H482-9. PubMed ID: 2137987
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced renal vasoconstriction induced by vasopressin in SHR is mediated by V1 receptors.
    Feng JJ; Arendshorst WJ
    Am J Physiol; 1996 Aug; 271(2 Pt 2):F304-13. PubMed ID: 8770161
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification and characterization of two classes of receptors for oxytocin and vasopressin in porcine tunica albuginea, epididymis, and vas deferens.
    Maggi M; Malozowski S; Kassis S; Guardabasso V; Rodbard D
    Endocrinology; 1987 Mar; 120(3):986-94. PubMed ID: 3026794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vasopressin antagonists block peripheral as well as central vasopressin receptors.
    De Wied D; Gaffori O; Van Ree JM; De Jong W
    Pharmacol Biochem Behav; 1984 Sep; 21(3):393-400. PubMed ID: 6093152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Arginine vasopressin increases renal sodium excretion in the anesthetized rat through V1 receptors.
    Musabayane CT; Forsling ML; Balment RJ
    Ren Fail; 1997 Jan; 19(1):23-32. PubMed ID: 9044449
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction between arginine vasopressin and angiotensin II receptors in the central regulation of sodium balance.
    Saad WA; Camargo LA; Antunes-Rodrigues J; Saad WA; Guarda IF; Guarda RS
    Regul Pept; 2005 Dec; 132(1-3):53-8. PubMed ID: 16198010
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of V1 and angiotensin receptor subtypes of the paraventricular nucleus on the water intake induced by vasopressin injected into the lateral septal area.
    de Arruda Camargo LA; Saad WA; Cerri PS
    Brain Res Bull; 2003 Sep; 61(5):481-7. PubMed ID: 13679246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Through the central V2, not V1 receptors influencing the endogenous opiate peptide system, arginine vasopressin, not oxytocin in the hypothalamic paraventricular nucleus involves in the antinociception in the rat.
    Yang J; Chen JM; Song CY; Liu WY; Wang G; Wang CH; Lin BC
    Brain Res; 2006 Jan; 1069(1):127-38. PubMed ID: 16409991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Central vasopressin V1-receptors mediate indomethacin-induced antipyresis in rats.
    Wilkinson MF; Kasting NW
    Am J Physiol; 1989 May; 256(5 Pt 2):R1164-8. PubMed ID: 2785772
    [TBL] [Abstract][Full Text] [Related]  

  • 34. V1-type vasopressin receptors in rat brain septum: binding characteristics and effects on inositol phospholipid metabolism.
    Shewey LM; Dorsa DM
    J Neurosci; 1988 May; 8(5):1671-7. PubMed ID: 2835449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Central cardiovascular effects of AVP and AVP analogs with V1, V2 and 'V3' agonistic or antagonistic properties in conscious dog.
    Noszczyk B; Lon S; Szczepańska-Sadowska E
    Brain Res; 1993 Apr; 610(1):115-26. PubMed ID: 8518919
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vascular vasopressin receptors mediate phosphatidylinositol turnover and calcium efflux in an established smooth muscle cell line.
    Aiyar N; Nambi P; Stassen FL; Crooke ST
    Life Sci; 1986 Jul; 39(1):37-45. PubMed ID: 3014249
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatic vasopressin receptor: differential effects of divalent cations, guanine nucleotides, and N-ethylmaleimide on agonist and antagonist interactions with the V1 subtype receptor.
    Gopalakrishnan V; McNeill JR; Sulakhe PV; Triggle CR
    Endocrinology; 1988 Aug; 123(2):922-31. PubMed ID: 2969327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vasopressin stimulates inositol phospholipid metabolism in rat medulla oblongata in vivo.
    Moratalla R; Vallejo M; Lightman SL
    Brain Res; 1988 May; 450(1-2):398-402. PubMed ID: 2969763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oxytocin causes endothelium-dependent relaxations of canine basilar arteries by activating V1-vasopressinergic receptors.
    Katusic ZS; Shepherd JT; Vanhoutte PM
    J Pharmacol Exp Ther; 1986 Jan; 236(1):166-70. PubMed ID: 3001282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human myometrium during pregnancy contains and responds to V1 vasopressin receptors as well as oxytocin receptors.
    Maggi M; Del Carlo P; Fantoni G; Giannini S; Torrisi C; Casparis D; Massi G; Serio M
    J Clin Endocrinol Metab; 1990 Apr; 70(4):1142-54. PubMed ID: 2156888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.